SCHEMBL7067558

SCHEMBL7067558

CCC(N)CC=Cc1cnc(N)nc1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.37
HRH3 Q9Y5N1 1/20 0.33
MASP2 O00187 1/20 0.32
CHRNB2 P17787 1/20 0.30
CHRNA4 P43681 1/20 0.30
CTSC P53634 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4422410 0.82 HTR2A (0.37) HTR2ACHRNB2CHRNA4CTSC
SCHEMBL4422413 0.82 HTR2A (0.37) HTR2ACHRNB2CHRNA4CTSC
SCHEMBL5878612 0.79 NOS3 (0.41) HTR2ACHRNB2CHRNA4
SCHEMBL5878615 0.79 NOS3 (0.41) HTR2ACHRNB2CHRNA4
SCHEMBL5198006 0.77 CHRNB2 (0.39) HTR2ACHRNB2CHRNA4
SCHEMBL5198003 0.77 CHRNB2 (0.39) HTR2ACHRNB2CHRNA4
SCHEMBL620193 0.74 CHRNB2 (0.56) HTR2AMASP2CHRNB2CHRNA4
SCHEMBL620192 0.74 CHRNB2 (0.56) HTR2AMASP2CHRNB2CHRNA4
SCHEMBL5199052 0.73 CHRNB2 (0.60) HTR2ACHRNB2CHRNA4
SCHEMBL3024293 0.73 CHRNB2 (0.60) HTR2ACHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317267-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE Targacept, Inc. (US) 2003-06-11 EP disclosed
EP-1311265-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS Targacept, Inc. (US) 2003-05-21 EP disclosed
WO-2002005801-A2 COMPOSITIONS CONTAINING DIACYLTARTARIC SALTS OF (E)-METANICOTINE TARGACEPT, INC. (US) 2002-01-24 WO disclosed
WO-2002005798-A2 PHARMACEUTICAL COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS TARGACEPT, INC. (US) 2002-01-24 WO disclosed